While attending iwCLL 2013, Dr. Richard Furman, a nationally recognized CLL clinician and researcher here in the Lymphoma Program, sat down and gave his thoughts on the latest advances in CLL treatment, and how this will effect future patient outcomes.
The discussion can be found here.
Like this:
Like Loading...
Related
Author: lymphomaprogram
Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.
View all posts by lymphomaprogram
New Developments in Lymphoma 